Neovasc said it had resolved the three claims of correction of patent inventorship made by Irvine, CA-based Edwards Lifesciences.
News & Features
In a new report, Decision Resources Group (DRG) experts have highlighted four medtech innovations that they see tearing up the script.
The company is bracing for a $25 million revenue hit after FDA ordered two of its mesh products off the market, but a bigger concern may be lying in wait.
The Abbott Park, IL-based has had a solid foundation of success dating back to the closure of the St. Jude Medical acquisition.
A new exo-suit technology from ReWalk aims to help stroke survivors regain their normal gait patterns.
FDA has ordered Boston Scientific and Coloplast to stop selling surgical mesh intended for transvaginal repair of pelvic organ prolapse. Patient advocates say the action was not made soon enough and does not go far enough, but it is a step in the right direction.
Results from the prospective, randomized, controlled, multi-surgeon clinical trial were published in Ophthalmology Glaucoma.
Johnson & Johnson’s earnings might have been down 14% when compared to last year, but the New Brunswick, NJ-based company was still able to beat analysts’ expectations.
With increasing competition, the way to gain market share in this quickly growing market is with innovative technology.
Intervention Insights' new platform, Trapelo, was designed to resolve the complexities of precision medicine in real time.
Roughly 28,000 new Bivona tracheostomy tubes manufactured by Smiths Medical are currently awaiting sterilization.